Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07545577

Randomized Controlld Trial of Dementia Education Resources for Action

The goal of this intervention trial is to evaluate the effectiveness the online training program Dementia Education and Resources for Action (DERA) in improving Alzheimer's disease and related dementia-(ADRD) knowledge, stigma, and service-related self-efficacy among community health workers (CHWs). We hypothesize that participants who have completed the DERA will have improved ADRD knowledge and self-efficacy in related service and reduced stigma against ADRD and people affected.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older
  • Currently working as a community health worker or serving in a community health worker-related role
  • Able to read and understand English
  • Has access to the internet and a computer, tablet, or smartphone to complete the online training and surveys
  • Willing and able to provide informed consent

Exclusion criteria

  • Previously completed the DERA training program
  • Unable to complete study procedures in English
  • Unable to access the online training platform or study surveys

Treatment and study plan

DERA Online Training Program

Behavioral

The Dementia Education and Resources for Action (DERA) program is a structured, online training intervention designed for community health workers. The program consists of approximately 7 sessions delivered through a web-based platform. Content includes dementia fundamentals, early signs and risk factors, stigma reduction, and strategies for communication, support, and service navigation. The training incorporates video-based instruction, interactive materials, and quizzes to support learning and engagement.

Primary outcomes

  1. Dementia Knowledge

    Time frame: Baseline to post-intervention (approximately 6-8 weeks)

    Dementia knowledge will be assessed using the Dementia Knowledge Assessment Scale (DKAS). The DKAS is a validated instrument that measures knowledge across multiple domains, including causes, symptoms, risk factors, and care considerations. DKAS-25 total score ranges from 0 to 50. Items are scored 0-2, with higher scores indicating greater dementia-related knowledge.

Secondary outcomes

  1. Dementia-Related Stigma

    Time frame: Baseline to post-intervention (approximately 6-8 weeks)

    Dementia-related stigma will be assessed using an adapted 8-item stigma scale with response options ranging from strongly disagree to strongly agree. Total scores range from 8 to 40, with higher scores indicating greater dementia-related stigma.

  2. Self-Efficacy in Dementia Care

    Time frame: Baseline to post-intervention (approximately 6-8 weeks)

    Self-efficacy will be measured using a study-specific Community Health Worker Dementia Role Self-Efficacy Scale assessing confidence in performing dementia-related tasks, including education, communication, support, and service navigation. Response options range from "Not at all confident" to "Extremely confident." Total scores range from 8 to 40, with higher scores indicating greater self-efficacy in dementia-related service delivery.

Study contacts

Contact information is provided by the study sponsor or research team.

Alicia Hong

CONTACT

[email protected]

7039931929

Sponsors and collaborators

Lead sponsor

George Mason University

Other

Registry information

Official study title

Evaluation of Dementia Education and Resources for Action

Acronym: DERA

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Apr 22, 2026
Registry last updated
May 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.